• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质复合物伙伴的调控作为非整倍体肿瘤的一种代偿机制。

Regulation of protein complex partners as a compensatory mechanism in aneuploid tumors.

机构信息

Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.

Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.

出版信息

Elife. 2022 May 16;11:e75526. doi: 10.7554/eLife.75526.

DOI:10.7554/eLife.75526
PMID:35575458
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9135399/
Abstract

Aneuploidy, a state of chromosome imbalance, is a hallmark of human tumors, but its role in cancer still remains to be fully elucidated. To understand the consequences of whole-chromosome-level aneuploidies on the proteome, we integrated aneuploidy, transcriptomic, and proteomic data from hundreds of The Cancer Genome Atlas/Clinical Proteomic Tumor Analysis Consortium tumor samples. We found a surprisingly large number of expression changes happened on other, non-aneuploid chromosomes. Moreover, we identified an association between those changes and co-complex members of proteins from aneuploid chromosomes. This co-abundance association is tightly regulated for aggregation-prone aneuploid proteins and those involved in a smaller number of complexes. On the other hand, we observed that complexes of the cellular core machinery are under functional selection to maintain their stoichiometric balance in aneuploid tumors. Ultimately, we provide evidence that those compensatory and functional maintenance mechanisms are established through post-translational control, and that the degree of success of a tumor to deal with aneuploidy-induced stoichiometric imbalance impacts the activation of cellular protein degradation programs and patient survival.

摘要

非整倍体,即染色体不平衡的状态,是人类肿瘤的标志特征,但它在癌症中的作用仍有待充分阐明。为了了解全染色体水平非整倍体对蛋白质组的影响,我们整合了来自数百个癌症基因组图谱/临床蛋白质组肿瘤分析联盟肿瘤样本的非整倍体、转录组和蛋白质组数据。我们发现,在其他非整倍体染色体上发生了大量出人意料的表达变化。此外,我们还发现这些变化与非整倍体染色体上蛋白质的共同复合物成员之间存在关联。对于易于聚集的非整倍体蛋白和那些参与数量较少复合物的蛋白,这种共同丰度的关联受到严格的调控。另一方面,我们观察到细胞核心机器的复合物受到功能选择的限制,以维持在非整倍体肿瘤中的化学计量平衡。最终,我们提供的证据表明,这些补偿和功能维持机制是通过翻译后控制建立的,肿瘤应对非整倍体诱导的化学计量失衡的成功程度会影响细胞蛋白质降解程序的激活和患者的生存。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14db/9135399/2e6cbd088407/elife-75526-sa2-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14db/9135399/a2822ab33911/elife-75526-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14db/9135399/7a035a7aa329/elife-75526-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14db/9135399/457601c6c73e/elife-75526-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14db/9135399/d184da510b88/elife-75526-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14db/9135399/38bdfaae8ee9/elife-75526-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14db/9135399/e8a57e385cbf/elife-75526-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14db/9135399/e34defcca2bf/elife-75526-fig3-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14db/9135399/ee1d2e0e3d60/elife-75526-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14db/9135399/93867d32a208/elife-75526-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14db/9135399/542cd93c43cb/elife-75526-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14db/9135399/241a20476489/elife-75526-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14db/9135399/66070956b7c4/elife-75526-fig6-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14db/9135399/d8944d85e79f/elife-75526-sa2-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14db/9135399/09bea581253f/elife-75526-sa2-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14db/9135399/2e6cbd088407/elife-75526-sa2-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14db/9135399/a2822ab33911/elife-75526-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14db/9135399/7a035a7aa329/elife-75526-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14db/9135399/457601c6c73e/elife-75526-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14db/9135399/d184da510b88/elife-75526-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14db/9135399/38bdfaae8ee9/elife-75526-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14db/9135399/e8a57e385cbf/elife-75526-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14db/9135399/e34defcca2bf/elife-75526-fig3-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14db/9135399/ee1d2e0e3d60/elife-75526-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14db/9135399/93867d32a208/elife-75526-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14db/9135399/542cd93c43cb/elife-75526-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14db/9135399/241a20476489/elife-75526-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14db/9135399/66070956b7c4/elife-75526-fig6-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14db/9135399/d8944d85e79f/elife-75526-sa2-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14db/9135399/09bea581253f/elife-75526-sa2-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14db/9135399/2e6cbd088407/elife-75526-sa2-fig3.jpg

相似文献

1
Regulation of protein complex partners as a compensatory mechanism in aneuploid tumors.蛋白质复合物伙伴的调控作为非整倍体肿瘤的一种代偿机制。
Elife. 2022 May 16;11:e75526. doi: 10.7554/eLife.75526.
2
Extensive protein dosage compensation in aneuploid human cancers.非整倍体人类癌症中的广泛蛋白质剂量补偿。
Genome Res. 2022 Jul;32(7):1254-1270. doi: 10.1101/gr.276378.121. Epub 2022 Jun 14.
3
Generation of aneuploid cells and assessment of their ability to survive in presence of chemotherapeutic agents.生成非整倍体细胞并评估其在化疗药物存在下的存活能力。
Methods Cell Biol. 2024;182:21-33. doi: 10.1016/bs.mcb.2022.10.012. Epub 2022 Nov 24.
4
Dynamic karyotype, dynamic proteome: buffering the effects of aneuploidy.动态核型,动态蛋白质组:缓冲非整倍体的影响。
Biochim Biophys Acta. 2014 Feb;1843(2):473-81. doi: 10.1016/j.bbamcr.2013.11.017. Epub 2013 Dec 1.
5
Cell competition removes segmental aneuploid cells from imaginal disc-derived tissues based on ribosomal protein gene dose.细胞竞争基于核糖体蛋白基因剂量从 imaginal 盘衍生组织中去除节段性非整倍体细胞。
Elife. 2021 Apr 13;10:e61172. doi: 10.7554/eLife.61172.
6
Chromosome-Specific and Global Effects of Aneuploidy in Saccharomyces cerevisiae.酿酒酵母中染色体特异性和非整倍体的全局效应
Genetics. 2016 Apr;202(4):1395-409. doi: 10.1534/genetics.115.185660. Epub 2016 Feb 2.
7
Effects of aneuploidy on gene expression: implications for cancer.非整倍体对基因表达的影响:对癌症的启示。
FEBS J. 2016 Mar;283(5):791-802. doi: 10.1111/febs.13591. Epub 2015 Dec 8.
8
Aneuploidy confers quantitative proteome changes and phenotypic variation in budding yeast.非整倍性导致芽殖酵母中蛋白质组的定量变化和表型变异。
Nature. 2010 Nov 11;468(7321):321-5. doi: 10.1038/nature09529. Epub 2010 Oct 20.
9
Protein aggregation mediates stoichiometry of protein complexes in aneuploid cells.蛋白质聚集介导非整倍体细胞中蛋白质复合物的化学计量。
Genes Dev. 2019 Aug 1;33(15-16):1031-1047. doi: 10.1101/gad.327494.119. Epub 2019 Jun 13.
10
The use of copy number loads to designate mosaicism in blastocyst stage PGT-A cycles: fewer is better.在囊胚期植入前基因检测-非整倍体(PGT-A)周期中使用拷贝数负荷来确定嵌合现象:越少越好。
Hum Reprod. 2023 May 2;38(5):982-991. doi: 10.1093/humrep/dead049.

引用本文的文献

1
Proteomic compensation by paralogs preserves protein interaction networks after gene loss in cancer.旁系同源物的蛋白质组补偿在癌症基因缺失后维持蛋白质相互作用网络。
Mol Syst Biol. 2025 May 28. doi: 10.1038/s44320-025-00122-4.
2
Multilevel Gene Expression Changes in Lineages Containing Adaptive Copy Number Variants.包含适应性拷贝数变异的谱系中的多级基因表达变化。
Mol Biol Evol. 2025 Feb 3;42(2). doi: 10.1093/molbev/msaf005.
3
Reduction of chromosomal instability and inflammation is a common aspect of adaptation to aneuploidy.染色体不稳定性和炎症的减少是细胞适应非整倍体的一个共同方面。

本文引用的文献

1
Extensive protein dosage compensation in aneuploid human cancers.非整倍体人类癌症中的广泛蛋白质剂量补偿。
Genome Res. 2022 Jul;32(7):1254-1270. doi: 10.1101/gr.276378.121. Epub 2022 Jun 14.
2
DNA methylation variation along the cancer epigenome and the identification of novel epigenetic driver events.沿着癌症表观基因组的 DNA 甲基化变异和新型表观遗传驱动事件的鉴定。
Nucleic Acids Res. 2021 Dec 16;49(22):12692-12705. doi: 10.1093/nar/gkab1167.
3
Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition.非整倍体使癌细胞易受有丝分裂检查点抑制的影响。
EMBO Rep. 2024 Nov;25(11):5169-5193. doi: 10.1038/s44319-024-00252-0. Epub 2024 Sep 18.
4
Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells.在人类非整倍体细胞中,增加RNA和蛋白质降解对于对抗转录负担和蛋白质毒性应激是必需的。
Cancer Discov. 2024 Dec 2;14(12):2532-2553. doi: 10.1158/2159-8290.CD-23-0309.
5
Natural proteome diversity links aneuploidy tolerance to protein turnover.天然蛋白质组多样性将非整倍体耐受性与蛋白质周转联系起来。
Nature. 2024 Jun;630(8015):149-157. doi: 10.1038/s41586-024-07442-9. Epub 2024 May 22.
6
The permissive binding theory of cancer.癌症的许可性结合理论。
Front Oncol. 2023 Nov 9;13:1272981. doi: 10.3389/fonc.2023.1272981. eCollection 2023.
7
Gene dosage compensation: Origins, criteria to identify compensated genes, and mechanisms including sensor loops as an emerging systems-level property in cancer.基因剂量补偿:起源、鉴定补偿基因的标准以及机制,包括作为癌症中新兴系统水平特性的传感器环。
Cancer Med. 2023 Dec;12(24):22130-22155. doi: 10.1002/cam4.6719. Epub 2023 Nov 21.
8
Multilevel gene expression changes in lineages containing adaptive copy number variants.包含适应性拷贝数变异的谱系中的多级基因表达变化。
bioRxiv. 2024 Jul 9:2023.10.20.563336. doi: 10.1101/2023.10.20.563336.
9
Compromised Mitotic Fidelity in Human Pluripotent Stem Cells.人类多能干细胞中的有丝分裂保真度受损。
Int J Mol Sci. 2023 Jul 25;24(15):11933. doi: 10.3390/ijms241511933.
10
Cancer genomes tolerate deleterious coding mutations through somatic copy number amplifications of wild-type regions.肿瘤基因组通过野生型区域的体细胞拷贝数扩增来容忍有害编码突变。
Nat Commun. 2023 Jun 16;14(1):3594. doi: 10.1038/s41467-023-39313-8.
Nature. 2021 Feb;590(7846):486-491. doi: 10.1038/s41586-020-03114-6. Epub 2021 Jan 27.
4
Genenames.org: the HGNC and VGNC resources in 2021.Genenames.org:2021 年的 HGNC 和 VGNC 资源。
Nucleic Acids Res. 2021 Jan 8;49(D1):D939-D946. doi: 10.1093/nar/gkaa980.
5
Ensembl 2021.Ensembl 2021.
Nucleic Acids Res. 2021 Jan 8;49(D1):D884-D891. doi: 10.1093/nar/gkaa942.
6
Aggregation and disaggregation features of the human proteome.人类蛋白质组的聚集和离散特征。
Mol Syst Biol. 2020 Oct;16(10):e9500. doi: 10.15252/msb.20209500.
7
Aneuploidy and gene expression: is there dosage compensation?非整倍体和基因表达:是否存在剂量补偿?
Epigenomics. 2019 Dec;11(16):1827-1837. doi: 10.2217/epi-2019-0135. Epub 2019 Nov 22.
8
Targeting transcription factors in cancer - from undruggable to reality.靶向癌症转录因子——从不可成药到现实。
Nat Rev Cancer. 2019 Nov;19(11):611-624. doi: 10.1038/s41568-019-0196-7. Epub 2019 Sep 11.
9
Multi-omics Characterization of Interaction-mediated Control of Human Protein Abundance levels.多组学分析交互作用介导的人类蛋白质丰度水平调控。
Mol Cell Proteomics. 2019 Aug 9;18(8 suppl 1):S114-S125. doi: 10.1074/mcp.RA118.001280. Epub 2019 Jun 25.
10
Protein aggregation mediates stoichiometry of protein complexes in aneuploid cells.蛋白质聚集介导非整倍体细胞中蛋白质复合物的化学计量。
Genes Dev. 2019 Aug 1;33(15-16):1031-1047. doi: 10.1101/gad.327494.119. Epub 2019 Jun 13.